PuSH - Publication Server of Helmholtz Zentrum München

47 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Parhofer, K.G.* et al.: Position paper on lipid therapy in patients with diabetes mellitus. Exp. Clin. Endocrinol. Diabet., DOI: 10.1055/a-1624-3572 (2022)
2.
Schuett, K.* et al.: Diabetes mellitus and the heart. Exp. Clin. Endocrinol. Diabet., DOI: 10.1055/a-1624-3593 (2022)
3.
Stefan, N. & Roden, M.*: Diabetes and fatty Liver. Exp. Clin. Endocrinol. Diabet. 64, DOI: 10.1055/a-1624-3541 (2022)
4.
Hörber, S. et al.: Carotid intima-media thickness is a predictor of subclinical myocardial damage in men with type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabet. 129, 750-756 (2021)
5.
Kern-Matschilles, S. et al.: Association of serum myostatin with body weight, visceral fat volume, and high sensitivity C-reactive protein but not with muscle mass and physical fitness in premenopausal women. Exp. Clin. Endocrinol. Diabet., DOI: 10.1055/a-1500-4605 (2021)
6.
Morgalla, M.H.* et al.: Influence of spinal cord stimulation on insulin sensitivity in chronic pain patients. Exp. Clin. Endocrinol. Diabet., DOI: 10.1055/a-1525-3339 (2021)
7.
Schäfer-Graf, U.* et al.: Gestational diabetes mellitus (GDM), diagnostics, therapy and follow-up care. Practice recommendation - Summary of the S3 guideline (AWMF register number: 057–008). Exp. Clin. Endocrinol. Diabet., DOI: 10.1055/a-1284-6011 (2021)
8.
Schäfer-Graf, U.* et al.: Correction: Gestational diabetes mellitus (GDM), diagnostics, therapy and follow-up care. Exp. Clin. Endocrinol. Diabet. 129, e1 (2021)
9.
Fritsche, A. et al.: Considering insulin secretory capacity as measured by a fasting c-peptide/glucose ratio in selecting glucose-lowering medications. Exp. Clin. Endocrinol. Diabet., DOI: 10.1055/a-1242-9809 (2020)
10.
Gerst, F. et al.: Glucose responsiveness of β-cell depends on fatty acids.  Exp. Clin. Endocrinol. Diabet. 128, 644-653 (2020)
11.
Jaghutriz, B.A. et al.: Metabolomic characteristics of fatty pancreas. Exp. Clin. Endocrinol. Diabet. 128, 804-810 (2020)
12.
Jaghutriz, B.A. et al.: The TUDID Study - background and design of a prospective cohort. Exp. Clin. Endocrinol. Diabet., DOI: 10.1055/a-1221-9618 (2020)
13.
Keuper, M. ; Häring, H.-U. & Staiger, H.: Circulating FGF21 levels in human health and metabolic disease. Exp. Clin. Endocrinol. Diabet. 128, 752-770 (2020)
14.
Krude, H.* ; Biebermann, H.* ; Schuelke, M.* ; Müller, T.D. & Tschöp, M.H.: Allan-herndon-dudley-syndrome: Considerations about the brain phenotype with implications for treatment strategies. Exp. Clin. Endocrinol. Diabet. 128, 414-422 (2020)
15.
Potasso, L.* et al.: Clinical impact of the TCF7L2 gene rs7903146 type 2 diabetes mellitus risk polymorphism in women with gestational diabetes mellitus: Impaired glycemic control and increased need of insulin therapy. Exp. Clin. Endocrinol. Diabet. 128, 663-666 (2020)
16.
Uter, J.C.* et al.: Single nucleotide polymorphisms in thyroid hormone transporter genes MCT8, MCT10 and deiodinase DIO2 contribute to inter-individual variance of executive functions and personality traits. Exp. Clin. Endocrinol. Diabet. 128, 573-581 (2020)
17.
Parhofer, K.G.* et al.: Position paper on lipid therapy in patients with diabetes mellitus. Exp. Clin. Endocrinol. Diabet. 127, S97-S101 (2019)
18.
Stangl, M.K.* et al.: Sarcopenia - Endocrinological and neurological aspects. Exp. Clin. Endocrinol. Diabet. 127, 8-22 (2019)
19.
Stefan, N. & Roden, M.*: Diabetes and fatty liver. Exp. Clin. Endocrinol. Diabet. 127, S93-S96 (2019)
20.
Zemva, J.* et al.: Effects of the reactive metabolite methylglyoxal on cellular signalling, insulin action and metabolism – What we know in mammals and what we can learn from yeast. Exp. Clin. Endocrinol. Diabet. 127, 203-214 (2019)